|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08156 SINOPHARM TECH
Nominal 
0.098 0.000 (0.000%) | 2023/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 18,844 | 25.418% | 15,025 | 11,730 | 55,200 | 87,380 |
| Cost of Sales | (15,723) | 31.178% | (11,986) | (9,137) | (35,648) | (64,668) |
| Gross Profit | 3,121 | 2.698% | 3,039 | 2,593 | 19,552 | 22,712 |
| 2023/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | (531) | 3,247 | 3,881 | 0 | |
| Profit / (Loss) before Taxation | (2,239) | -- | 15,769 | (13,377) | (14,627) | (17,121) | |
| Taxation | 0 | -- | 0 | 0 | 0 | (1,149) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (637) | 76.454% | (361) | (126) | 487 | 1,035 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (2,876) | -- | 15,408 | (13,503) | (14,140) | (17,235) | |
| 2023/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | 1,875 | -53.137% | 4,001 | 9,068 | 10,015 | 7,229 |
| Depreciation & Amortisation | 240 | -65.318% | 692 | 668 | 1,598 | 3,719 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2023/12 - Interim | %Chg (Compare to Interim) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2023/12 - Interim | %Chg (Compare to Interim) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -1.570 | -- | 8.460 | -7.500 | -8.250 | -10.500 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | (0.960) | -- | (0.815) | (0.665218) | (0.493371) | 0.145418 |
| Remarks: | Real time quote last updated: 25/11/2024 09:50 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -2,876,000 |
| %Change | -- |
| EPS / (LPS) | HKD -0.016 |
| NBV Per Share ($) | HKD -0.960 |